News Detail

New Delhi, 3 May 2024: The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling prices of coronary stents with effect from the beginning of April, 2024, in tune with the Wholesale Price Index (WPI) change for the year 2023 over the previous year.
Th......
View Details
Source : Pharmabiz
National Pharmaceutical Pricing Authority
NPPA
coronary stents
WPI
Wholesale Price Index
drug eluting stents
DES
Bioresorbable Vascular Scaffold
BVS
Drugs and Cosmetics Act
NLEM 2022
DPCO
2013
Related News
- Critical medicines for cancer, diabetes set to get expensive as govt clears price hike, say sources (27-03-2025)
- DGFT proposes mandatory GST E-Invoices for pharma export benefits (27-03-2025)
- US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome (27-03-2025)
- FDA approves GSK’s 'Blujepa' for uncomplicated UTIs (27-03-2025)
- Bengal drug control publishes helpline to report fake medicines (27-03-2025)
- Misleading ads: SC asks states UTs to set up grievance redressal mechanism (26-03-2025)
- WHO partners with regulators, experts to strengthen safety and access of medical devices (26-03-2025)
- PCI warns of tough action against inspectors who don't follow its guidelines during inspection (26-03-2025)
- Seizure of fake Human Albumin Vials rings alarm bells (26-03-2025)
- Pharmacy owner, three others held for illegal sale of intoxication drug (26-03-2025)